title: Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review.
abstract: This study compared the economic value of pediatric immunisation programmes for influenza to those for rotavirus (RV), meningococcal disease (MD), pneumococcal disease (PD), human papillomavirus (HPV), hepatitis B (Hep B), and varicella reported in recent (2000 onwards) cost-effectiveness (CE) studies identified in a systematic review of PubMed, health technology, and vaccination databases. The systematic review yielded 51 economic evaluation studies of pediatric immunisation - 10 (20%) for influenza and 41 (80%) for the other selected diseases. The quality of the eligible articles was assessed using Drummond's checklist. Although inherent challenges and limitations exist when comparing economic evaluations of immunisation programmes, an overall comparison of the included studies demonstrated cost-effectiveness/cost saving for influenza from a European-Union-Five (EU5) and United States (US) perspective; point estimates for cost/quality-adjusted life-years (QALY) from dominance (cost-saving with more effect) to ≤45,444 were reported. The economic value of influenza programmes was comparable to the other vaccines of interest, with cost/QALY in general considerably lower than RV, Hep B, MD and PD. Independent of the perspective and type of analysis, the economic impact of a pediatric influenza immunisation program was influenced by vaccine efficacy, immunisation coverage, costs, and most significantly by herd immunity. This review suggests that pediatric influenza immunisation may offer a cost effective strategy when compared with HPV and varicella and possibly more value compared with other childhood vaccines (RV, Hep B, MD and PD).
authors.affiliation: a Wickenstones , Reading , UK.
authors.forename: Edward
authors.initials: E
authors.lastname: Gibson
authors.affiliation: a Wickenstones , Reading , UK.
authors.forename: Najida
authors.initials: N
authors.lastname: Begum
authors.affiliation: a Wickenstones , Reading , UK.
authors.forename: Birgir
authors.initials: B
authors.lastname: Sigmundsson
authors.affiliation: b AstraZeneca , Cambridge , UK.
authors.forename: Alfred
authors.initials: A
authors.lastname: Sackeyfio
authors.affiliation: c AstraZeneca , Gaithersburg , MD , USA.
authors.forename: Judith
authors.initials: J
authors.lastname: Hackett
authors.affiliation: d AstraZeneca , Paddington , London , UK.
authors.forename: Sankarasubramanian
authors.initials: S
authors.lastname: Rajaram
mesh_terms: D000293:Adolescent; D019433:Chickenpox Vaccine / Q000191:economics; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D005060:Europe; D005260:Female; D017325:Hepatitis B Vaccines / Q000191:economics; D006801:Humans; D032521:Immunity, Herd; D017589:Immunization Programs / Q000191:economics*; D007223:Infant; D007252:Influenza Vaccines / Q000191:economics*; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D022401:Meningococcal Vaccines / Q000191:economics; D053918:Papillomavirus Vaccines / Q000191:economics; D011008:Pneumococcal Infections / Q000517:prevention & control; D022242:Pneumococcal Vaccines / Q000191:economics; D019057:Quality-Adjusted Life Years; D022243:Rotavirus Vaccines / Q000191:economics; D014481:United States
chemical_list: D019433:Chickenpox Vaccine; D017325:Hepatitis B Vaccines; D007252:Influenza Vaccines; D022401:Meningococcal Vaccines; D053918:Papillomavirus Vaccines; D022242:Pneumococcal Vaccines; D022243:Rotavirus Vaccines
keywords: cost-effectiveness; economic evaluation; influenza; pediatric immunisation program; vaccines
references.citation: J Infect. 2007 Jun;54(6):530-8
references.pmid: 17097147
references.citation: Annu Rev Med. 2006;57:139-54
references.pmid: 16409141
references.citation: BMJ. 2012 Jul 12;345:e4445
references.pmid: 22791791
references.citation: BMJ. 1996 Aug 3;313(7052):275-83
references.pmid: 8704542
references.citation: Vaccine. 2009 Oct 19;27(44):6121-8
references.pmid: 19715781
references.citation: Vaccine. 2009 Jul 16;27(33):4520-8
references.pmid: 19446594
references.citation: Pharmacoeconomics. 2003;21(8):587-600
references.pmid: 12751916
references.citation: Vaccine. 2011 Nov 28;29(51):9521-8
references.pmid: 22008820
references.citation: Eur J Health Econ. 2009 Feb;10(1):25-38
references.pmid: 18379830
references.citation: J Hyg (Lond). 1981 Feb;86(1):35-47
references.pmid: 7462597
references.citation: Pediatrics. 2001 Aug;108(2):E24
references.pmid: 11483834
references.citation: Vaccine. 2000 Feb 18;18 Suppl 1:S86-9
references.pmid: 10683559
references.citation: Pediatrics. 2014 Apr;133(4):577-85
references.pmid: 24590750
references.citation: Clin Infect Dis. 2001 Dec 1;33(11):1879-85
references.pmid: 11692300
references.citation: Vaccine. 2011 Dec 6;29(52):9640-8
references.pmid: 22027484
references.citation: Emerg Infect Dis. 2008 Feb;14(2):244-51
references.pmid: 18258117
references.citation: Vaccine. 2009 Nov 5;27(47):6483-94
references.pmid: 19720366
references.citation: Vaccine. 2010 Mar 11;28(12):2370-84
references.pmid: 20096762
references.citation: Vaccine. 2013 Jan 30;31(6):927-42
references.pmid: 23246550
references.citation: BMJ. 2014 Oct 09;349:g5725
references.pmid: 25301037
references.citation: Eur J Pediatr. 2014 Mar;173(3):265-76
references.pmid: 23661234
references.citation: Vaccine. 2007 Nov 19;25(47):8010-20
references.pmid: 17936446
references.citation: Lancet Infect Dis. 2008 Nov;8(11):727-33
references.pmid: 18992409
references.citation: Int J Technol Assess Health Care. 2008 Winter;24(1):10-9
references.pmid: 18218164
references.citation: Ann Intern Med. 2009 Aug 18;151(4):W65-94
references.pmid: 19622512
references.citation: Vaccine. 2011 Jan 10;29(3):466-75
references.pmid: 21073988
references.citation: Eur J Cancer. 2010 Nov;46(16):2973-85
references.pmid: 20638840
references.citation: PLoS One. 2011;6(7):e22308
references.pmid: 21829456
references.citation: Vaccine. 2015 Mar 30;33(14):1633-58
references.pmid: 25681663
references.citation: Value Health. 2005 May-Jun;8(3):209-22
references.pmid: 15877593
references.citation: Hum Vaccin. 2007 Jan-Feb;3(1):14-22
references.pmid: 17245134
references.citation: N Engl J Med. 1978 Mar 16;298(11):587-92
references.pmid: 628375
references.citation: Arch Pediatr Adolesc Med. 2011 Feb;165(2):112-8
references.pmid: 20921341
references.citation: Pediatr Infect Dis J. 2006 Oct;25(10):870-9
references.pmid: 17006279
references.citation: BMJ. 2008 Jul 17;337:a769
references.pmid: 18640957
references.citation: JAMA. 2000 Mar 15;283(11):1460-8
references.pmid: 10732936
references.citation: BMJ. 2002 Apr 6;324(7341):809
references.pmid: 11934772
references.citation: Eur J Health Econ. 2008 Feb;9(1):7-15
references.pmid: 17333089
references.citation: Vaccine. 2004 Sep 9;22(27-28):3546-62
references.pmid: 15315834
references.citation: Health Econ Rev. 2013 Nov 18;3(1):27
references.pmid: 24246029
references.citation: Vaccine. 2010 Mar 8;28(11):2356-9
references.pmid: 19567247
references.citation: Vaccine. 2011 Oct 6;29(43):7554-8
references.pmid: 21820477
references.citation: Vaccine. 2013 May 28;31(23):2638-46
references.pmid: 23566946
references.citation: Vaccine. 2004 Oct 22;22(31-32):4203-14
references.pmid: 15474710
references.citation: Vaccine. 2006 Nov 17;24(47-48):6980-9
references.pmid: 16860909
references.citation: Vaccine. 2012 Nov 6;30(48):6766-76
references.pmid: 23000223
references.citation: Vaccine. 2009 Jun 12;27(29):3904-11
references.pmid: 19446934
references.citation: Vaccine. 2008 Jan 30;26(5):706-15
references.pmid: 18166250
references.citation: J Infect Dis. 2008 Mar 1;197 Suppl 2:S156-64
references.pmid: 18419391
references.citation: Hum Vaccin Immunother. 2012 Jan;8(1):119-29
references.pmid: 22251999
references.citation: Prev Med. 2014 Apr;61:116-21
references.pmid: 24360847
references.citation: BMJ. 2011 Sep 27;343:d5775
references.pmid: 21951758
references.citation: Vaccine. 2009 Jun 19;27(30):4025-30
references.pmid: 19389452
references.citation: Health Policy. 2009 Feb;89(2):225-38
references.pmid: 18639952
references.citation: Emerg Infect Dis. 2003 Jan;9(1):37-48
references.pmid: 12533280
references.citation: Vaccine. 2014 Apr 7;32(17):1964-74
references.pmid: 24561052
references.citation: Gynecol Oncol. 2009 Feb;112(2):370-6
references.pmid: 19041125
references.citation: Pediatrics. 2008 Jan;121 Suppl 1:S63-78
references.pmid: 18174323
references.citation: J Natl Cancer Inst. 2008 Mar 5;100(5):308-20
references.pmid: 18314477
references.citation: Vaccine. 2009 May 26;27(25-26):3450-3
references.pmid: 19200850
references.citation: Pediatr Infect Dis J. 2006 Jun;25(6):494-501
references.pmid: 16732146
references.citation: Hum Vaccin Immunother. 2013 May;9(5):1119-28
references.pmid: 23376840
references.citation: Vaccine. 2012 Jan 20;30(5):886-92
references.pmid: 22155144
references.citation: Value Health. 2008 Dec;11(7):1022-32
references.pmid: 18489503